Hospital for Special Surgery, New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hospital for Special Surgery, New York sits in the top decile of US sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count).
Hospital for Special Surgery, New York: 194 sponsored US clinical trials, 35 recruiting.
Hospital for Special Surgery, New York sponsors 194 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 123 completed. 58 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use, with 7 trials.
Top-decile sponsor footprint
Hospital for Special Surgery, New York ranks in the top decile of sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 145 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
194 total, page 2 of 4
Mindfulness Meditation Intervention Study
NCT06180486
Agility and Performance Among High School Basketball Players Following a Coach-Led Neuromuscular Training Program
NCT07023276
Aromatherapy in Total Knee Replacement
NCT06045078
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
NCT06003985
RIIP REPS Neuromuscular Training
NCT07221305
Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty
NCT05980546
Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
NCT05720949
Infrared Imaging in Complex Regional Pain Syndrome
NCT05693337
Cannabidiol for Bilateral Total Knee Arthroplasty
NCT04749628
Opioid Education in Total Knee Arthroplasty
NCT05593341
Effects of Continuous ESP Catheters on Recovery, Pain and Opioid Consumption After Multilevel Spine Surgery
NCT05494125
MIDCAB (Mid-Calf Block) for Foot Surgery
NCT05368012
Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery
NCT05384860
TKA Melatonin and Sleep Quality
NCT05332717
Pre-post Spinal Popliteal Block
NCT05354791
Dronabinol in Total Knee Arthroplasty (TKA)
NCT04734080
Erector Spinae Plane Blocks for Adolescent Idiopathic Scoliosis
NCT04500613
Does PAI Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving ACB & IPACK?
NCT04749615
Abaloparatide and Pelvic Fracture Healing
NCT04249232
Patient Knowledge on Pain Management and Safe Opioid Use
NCT04498559
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists
NCT04389294
Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery
NCT04156581
Lipogems Prospective Study
NCT03922490
Oral Versus Intravenous Tranexamic Acid
NCT04089865
Acupuncture for Low-Dose Opioid for TKA Replacement
NCT04084288
Liposomal Bupivacaine vs Dexamethasone ISB
NCT04047446
Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty
NCT03973320
The Effects of Dexmedetomidine Dose on Motor Evoked Potentials
NCT03378973
Acupuncture ACL (Anterior Cruciate Ligament)
NCT03711734
Core Strengthening for DRA in Postpartum Women
NCT03595696
Rotator Cuff Pathway
NCT03717753
rTMS in Treatment of Spasticity
NCT04054141
Virtual Reality Distraction During Outpatient Pediatric Orthopedic Procedures
NCT05510232
Chloroprocaine Spinal for Outpatient Knee Surgery
NCT03365752
Evaluation of Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Arthroscopy
NCT03432650
Acupuncture for Pre-Procedure Anxiety
NCT03480919
Maveric Magnetic Resonance Imaging Used to Study Detailed Bone Apposition and Fixation of the Stryker Trident II Tritanium System
NCT03469817
Metal Ion Levels in Stryker Trident II Tritanium System with Modular Dual Mobility (MDM) Liner, Ceramic Head, and SecurFit Advanced Stems
NCT03433742
Muscle Elastography in Spastic Cerebral Palsy
NCT03112434
Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS
NCT03373981
A Novel Analgesia Technique for ACL Reconstruction
NCT03292926
Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty
NCT03271151
Interscalene Block Versus Superior Trunk Block
NCT03272139
Evaluation of Methods of Teaching Self-management Strategies to Patients With Symptomatic Knee Osteoarthritis
NCT03245463
Patient Education and Use of Post Operative Pain Medication in Ambulatory Hand Surgery: a Randomized Controlled Trial
NCT03219177
PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
NCT02972424
Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis
NCT03130335
Minimal Opioid Use After Total Hip Replacement (THR)
NCT03090152
Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)
NCT03094663
IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty
NCT03020966
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 14 |
| Phase 3 | 8 |
| Phase 4 | 50 |
Therapeutic Areas
Where Hospital for Special Surgery, New York enrollment is open (later-stage tilt)
35 recruiting of 194 indexed (18% open); 123 completed (63%).
Phase mix: 58 late (III/IV) vs 19 early (I/II) (later-stage heavy).
Top condition: Opioid Use (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hospital for Special Surgery, New York: open-pipeline peers nationwide
Peers matched on 194 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Hospital for Special Surgery, New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 194 trials (± recruiting share)
- Genzyme, a Sanofi Company · 196 trials · 2% recruiting
- Vertex Pharmaceuticals Incorporated · 191 trials · 10% recruiting
- Vanderbilt-Ingram Cancer Center · 189 trials · 15% recruiting
- Nationwide Children's Hospital · 188 trials · 15% recruiting
Sponsors near 18% open enrollment (± trial volume)
- George Washington University · 18% recruiting · 133 trials
- West Virginia University · 18% recruiting · 122 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
Related
What to do with this Hospital for Special Surgery, New York page
194 registered trials is a research-attention snapshot, not an endorsement of Hospital for Special Surgery, New York or any single study.
- 35 of Hospital for Special Surgery, New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use is the condition Hospital for Special Surgery, New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hospital for Special Surgery, New York pipeline card: 194 registered trials from official public datasets.Report a data error.